TerrAscend (TSNDF) EBITDA Margin (2021 - 2026)

TerrAscend (TSNDF) reported EBITDA Margin of 11.75% for Q1 2026, up 731.0% year-over-year from 1.41% in Q1 2025, and down 327.56% quarter-over-quarter from 5.16% in Q4 2025.

TerrAscend (TSNDF) EBITDA Margin (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of EBITDA Margin data on file, last reported at 11.75% in Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 11.75%, up 731.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 29.72% (down 340.0% YoY), and the FY2025 annual result was 31.61%, down 495.0% from the prior year.
  • EBITDA Margin declined to 11.75% in Q1 2026 per TSNDF's latest filing, from 5.16% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 21.7% in Q2 2022 and troughed at 465.3% in Q3 2022.
  • A 5-year average of 58.17% and a median of 19.06% in 2025 frame the typical range for EBITDA Margin.
  • The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 46604 bps in 2022, then surged 45589 bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 17.57% in 2022, then tumbled by 1100 bps to 210.79% in 2023, then jumped by 80 bps to 41.74% in 2024, then surged by 112 bps to 5.16% in 2025, then plunged by 328 bps to 11.75% in 2026.
  • Business Quant data shows TSNDF's EBITDA Margin at 11.75% in Q1 2026, 5.16% in Q4 2025, and 37.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 16.37%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 36.83%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 22.39%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -170.35%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -16.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 21.55%
10 TerrAscend - - 34.60 Mn -11.75%

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.75%
Dec 31, 2025 5.16%
Sep 30, 2025 -37.72%
Jun 30, 2025 -75.32%
Mar 31, 2025 -19.06%
Dec 31, 2024 -41.74%
Sep 30, 2024 -35.74%
Jun 30, 2024 -8.89%
Mar 31, 2024 -17.92%
Dec 31, 2023 -210.79%
Sep 30, 2023 -9.40%
Jun 30, 2023 -19.25%
Mar 31, 2023 -33.31%
Dec 31, 2022 -17.57%
Sep 30, 2022 -465.30%
Jun 30, 2022 21.70%
Mar 31, 2022 -11.90%
Dec 31, 2021 34.22%
Sep 30, 2021 0.74%
Jun 30, 2021 23.92%